Global Vaccine CDMO Market is estimated to grow at a 8-10% CAGR and poised to reach $5 billion by 2025 - Lonza, Catalent, Patheon, IDT, Wuxi Biologics, Fujifilm, Emergent BioSolutions, Halix, Cobra Biologics, Wacker

The global Vaccine CDMO market is driven by increasing demand from biotech vaccine developers & more selective outsourcing by pharmaceutical companies.

Vaccine manufacturing is a highly complex process compared to small molecules. Currently, the penetration of CDMO is less than 20% of overall manufacturing value with ample opportunity for growth. There is growing trend towards outsourcing by the pharma and biotech industry for vaccine development and manufacturing. While biotech companies largely lack internal capabilities on process development and in-house manufacturing facilities qualified with GMP or BSL1 or BSL2 levels; big pharma companies mainly approach CDMOs for high volume vaccine manufacturing, risk mitigation and fill and finish activities. Also, large pharma may struggle to meet rising demand for new technology vaccines like viral vector and mRNA. Moreover, increased interest in development of newer vaccines like shingles, RSV, infectious diseases by smaller biotech companies, will in turn offer growth opportunities for vaccine CDMOs.

Medi-Tech Insights’ latest report on Vaccine CDMOs analyses the Vaccine CDMO market with respect to service type, scale of operation, technology, end user, and region.

For Customized Report, Contact Us @ https://meditechinsights.com/contact-us/

Based on our research & interviews with industry experts, currently, CDMOs derive most of their revenues from commercial manufacturing (drug substance/drug product manufacturing (including fill-n-finish) however, increasingly the pharma biotech companies are reaching out to CDMOs for development services as well.

While majority volumes for vaccines are driven by emerging countries, most of the value is driven by North America & Europe. By technology, mRNA have great potential but other technologies like live-attenuated, inactivated and subunit will remain important in global Vaccine CDMO Market.

Competitive Landscape Analysis: Vaccine CDMO Market

There are limited number of CDMOs who are able to offer full service and have expertise in newer platforms like mRNA/viral vector. Some of the leading players operating in the Vaccine CDMO market are Lonza, Catalent, Patheon, IDT, Wuxi Biologics, Fujifilm, and Emergent BioSolutions. On the other hand, there are several promising players in the global Vaccine CDMO market such as Halix, Cobra Biologics, Wacker, Batavia Biosciences, Biovian, Novasep, and Vibalogics. Among Asian players, Wuxi Biologics, SK Bioscience, and Samsung Biologics are expected to compete with Western players (using their US/EU presence) in the Vaccine CDMO market. The research report on global Vaccine CDMO market provides detailed analysis of key players with respect to their business and financial overview, competitive positioning, key growth strategies, and developments.

Medi-Tech Insights’ latest report on global Vaccine CDMO Market comprehensively analyses key areas looked by the pharma and biotech companies while shortlisting a CDMO.

The quality of product coming out of the production line and technical expertise are of utmost importance while selecting a CDMO. Furthermore, regulatory compliance/certifications, facilities, capacity, supplier’s business profile, cost and scalability are some of the other factor’s pharma and biotech companies consider while making a decision.

Sources: Medi-Tech Insights Analysis, Expert Interviews

For More Detailed Insights, Get in Touch with Us @ https://meditechinsights.com/contact-us/

Ruta Halde
Medi-Tech Insights
Tel No: +32 498 86 80 79
Email: info@meditechinsights.com
Website: https://meditechinsights.com/

Medi-Tech Insights is a healthcare-focused business research & insights firm. Our clients include Fortune 500 companies, blue-chip investors & hyper-growth start-ups. We have successfully completed 100+ projects in Digital Health, Healthcare IT, Medical Technology, Medical Devices & Pharma Services in the areas of market assessments, due diligence, competitive intelligence, market sizing and forecasting, pricing analysis & go-to-market strategy.

This release was published on openPR.